Shares of Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR – Get Free Report) passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.01 and traded as low as $0.00. Acura Pharmaceuticals shares last traded at $0.00, with a volume of 52,127 shares trading hands.
Acura Pharmaceuticals Stock Down 94.3 %
Acura Pharmaceuticals Company Profile
Acura Pharmaceuticals, Inc, an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.
Recommended Stories
- Five stocks we like better than Acura Pharmaceuticals
- The 3 Best Fintech Stocks to Buy Now
- 3 Legacy Tech Companies Reemerging as AI Leaders
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- What Investors Need to Know to Beat the Market
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
